• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search
  • Facial Plastic/Reconstructive
  • Head and Neck
  • Laryngology
  • Otology/Neurotology
  • Pediatric
  • Rhinology
  • Sleep Medicine
  • How I Do It
  • TRIO Best Practices

Practice Focus » Sleep Medicine

What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

May 6, 2025

Hypoglossal nerve stimulation (HGNS) therapy has become a more frequently employed tool in the treatment of obstructive sleep apnea since its approval by the U.S. Food and Drug Administration in 2014. One of the benefits of HGNS therapy is the low morbidity associated with the procedure.

Opioid Prescription Stable Among Sleep Surgeons, While Opioid Costs Trend Downward

January 8, 2025

Opioid prescription patterns among sleep surgeons in the U.S. remained stable from 2013 to 2021; surgeons with longer tenures exhibited higher rates of opioid prescribing during this time.

What Are the Predictors of Success with Hypoglossal Nerve Stimulation?

January 8, 2025

HNS was approved by the U.S. Food and Drug Administration in 2014 as a treatment option for patients with moderate to severe OSA who cannot tolerate CPAP.

Tirzepatide Reduces Sleep Impairment and Cardiovascular Risk Factors in Patients with Moderate-to-Severe OSA

November 5, 2024

In two trials, participants with OSA and obesity who received tirzepatide had a clinically meaningful change in sleep-disordered breathing and alleviation of perceived sleep disturbance and sleep-related impairment, as well as reductions in common OSA-related cardiovascular risk factors.

Where Does Hypoglossal Nerve Stimulator Implant Fit in the Surgical Management Algorithm of Obstructive Sleep Apnea? 

August 6, 2024

Hypoglossal Nerve Stimulator therapy is an effective and safe surgical option for patients with moderate to severe OSA who cannot tolerate PAP therapy. 

Tirzepatide Makes a Big Splash, but What Else is on the Horizon for OSA? 

August 6, 2024

When it comes to drug therapy most of the recent buzz has been triggered by data on tirzepatide released at the American Diabetes Association 84th Scientific Sessions, suggesting that the drug may obviate the need for continuous positive airway pressure (CPAP) in nearly half of OSA patients. 

Pages: 1 2 3 | Single Page

Propofol Application Rate Pattern Found Suitable for Performing Sedation-Controlled DISE in Patients with Obstructive Sleep Apnea and/or Snoring 

August 6, 2024

What are the influences of different rates of propofol application on the achieved depth and length of the sedation course during drug-induced endoscopy (DISE)? 

Sleep Apnea Symptoms May Be Linked to Problems with Memory and Thinking Abilities

June 17, 2024

A new preliminary study at the American Academy of Neurology’s 76th Annual Meeting in Denver showed a positive association between sleep apnea and cognitive decline

Identifying and Managing Sensing Lead Malfunction in Upper Airway Stimulation Devices

June 17, 2024

Identifying and managing sensing lead malfunction in upper airway stimulation devices using the Inspire Medical Systems’ upper airway stimulation (UAS) device to treat patients with moderate to severe obstructive sleep apnea (OSA), to necessitate revision surgery.

Sleep Position, BMI May Affect Hypoglossal Nerve Stimulation Success

May 13, 2024

While hypoglossal nerve stimulation can be effective for treating obstructive sleep apnea, factors such as weight and sleep position can decrease its effectiveness

  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939